Ads
related to: clinical trials
Search results
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 6 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 2 days agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
Obituaries in Asheville, NC | Asheville Citizen-Times
Asheville Citizen-Times· 2 hours agoLinda was born in France on April 30, 1955, to David Perry McDuffee and Margaret Howard McDuffee. Linda passed away after a long illness at 69 years old. Linda is survived by her husband of ...
Boomer Esiason apologizes to Mets pitcher, says team fumbled situation: ‘It’s just not appropriate’
NJ.com· 6 hours agoBoomer Esiason, the current WFAN host and 1988 NFL MVP, is taking back the comments he made about...
Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology
FierceBiotech· 11 hours agoThis story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....
GeoVax to Present at BIO International Convention 2024
Digital Journal· 1 day agoThe company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin (R) , which recently completed enrollment in a multicenter Phase 1/2 clinical ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 hours agoThe presentation will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com. Immunocore ...
Earnings call: Roivant reveals Q4 2023 results and strategic growth plans By Investing.com
Investing.com· 5 hours agoRoivant Sciences (NASDAQ:ROIV), in its Fourth Quarter 2023 Earnings Conference Call, outlined its...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga via Yahoo Finance· 1 day agoWednesday, Johnson & Johnson (NYSE:JNJ) announced topline results from Phase 3 MDD3001 clinical ...